DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Getting ahead of the digital health avalanche How can a health system know which innovative tools are worth its time?

Half of radiologists have net worth of $2 million or more New survey analyzed responses from over 20,000 physicians in over 30 specialties

Varian to acquire Cancer Treatment Services International for $283 million Enables production of multidisciplinary solutions

FBI opens probe into alleged kickbacks by healthcare OEMs in Brazil Accused of making bribes to sell medical equipment

icometrix raises $18 million in funding Will help with deployment of icobrain software in Europe

Q&A with Michael Darling, VP Supply Chain, St. Luke’s Health System Discussing the clinical integration of supply chain

Consolidation, consumerism and telehealth are the top three industry trends for 2019 According to a wide sampling of 1,000 healthcare stakeholders

Varian acquires CyberHeart, enters cardiac radioablation market Emerging technology could benefit treatment of irregular heartbeats

M&A trend lines in tech-enabled medical devices Connecting the dots on industry consolidation

Siemens' push to install Atellica systems may hurt full-year profits Still, Q2 growth 'clearly accelerated'

Varian, Elekta settle radiotherapy patent dispute

by Thomas Dworetzky , Contributing Reporter
Varian Medical Systems and Elekta have resolved their multi-year dispute and arrived at a confidential settlement agreement.

This ends their ongoing patent litigation “involving technology used for radiation oncology and the treatment of cancer,” Varian said in a statement.

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



The resolution, which includes the suit brought by Elekta AB and William Beaumont Hospital, includes “no payments exchanged by the plaintiffs and defendants and no future financial obligations,” according to Varian.

In June, 2015, Sweden-based Elekta and William Beaumont Hospital in Michigan sued Varian over alleged infringements of patents owned by the hospital, and that are licensed to Elekta.

The lawsuit was filed in U.S. District Court for the Eastern District of Michigan.

The claim was that Varian’s True Beam linear accelerator infringed on patents titled “Cone Beam Computed Tomography With A Flat Panel Imager” from William Beaumont Hospital.

“Elekta Ltd. is the exclusive licensee of William Beaumont Hospital for the Patents-in-Suit,” wrote Gert van Santen, an Elekta spokesman, in an email to HCB News at that time. “We decided to sue Varian because we want to defend our assets.”

Varian disputed the claim. Meryl Ginsberg, a spokeswoman for the Palo Alto-based company told HCB News in an email that, “we have our own cone-beam CT technology which we use on our imaging accessories,” adding that, “we will do business as usual and defend ourselves vigorously.”

In September, 2015, Varian had filed its own patent infringement lawsuit.

In November, 2016, an administrative law judge with the U.S. International Trade Commission (USITC) issued an initial determination in favor of Varian on its volumetric-modulated arc therapy (VMAT) patents in litigation with Elekta, according to a statement issued by Varian at that time.

The decision found violations of Section 337 based on Elekta's importation and sale of radiotherapy systems using linear accelerator-based VMAT technology.

Varian had claimed the machines imported by Elekta violated patents, which covered “the design of the machines and the radiation emitters, the methods by which they are used to target tumors, and the control software,” according to Law 360.

Elekta claimed that the patents were “obvious and contain claims that were anticipated by a 1998 patent and two medical journal articles from 2002 and 2003,” and were thus invalid, according to the legal site.

At that time, Varian reported that the law judge recommended that the USITC issue cease-and-desist and limited-exclusion orders preventing Elekta from selling and importing its radiotherapy systems with infringing VMAT capabilities into the U.S.

"We are pleased with the ITC ruling on the validity and infringement of Varian's VMAT patents," said John W. Kuo, Varian senior vice president and general counsel. "We see this as a victory for innovation and cutting edge cancer treatments that can benefit all patients. We look forward to the resolution of this litigation so that all parties can return all of their focus to the mission of developing and providing technology that will help to save the lives of cancer patients."

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED